UPDATE: Credit Suisse Reiterates On Biogen Idec On Gilenya PPMS Risk
November 19, 2014 at 09:58 AM EST
In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated an Outperform rating on Biogen Idec Inc (NASDAQ: BIIB), ...